...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Design, synthesis, and biological evaluation of 4-H pyran derivatives as antimicrobial and anticancer agents
【24h】

Design, synthesis, and biological evaluation of 4-H pyran derivatives as antimicrobial and anticancer agents

机译:4-H吡喃衍生物作为抗微生物和抗癌剂的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of pyran derivatives (5-27) were synthesized in good yields by utilizing Baylis-Hillman chemistry and were further investigated for their in vitro anticancer, antibacterial, and antifungal activities. Most of the tested compounds exhibited promising antibacterial activity as compared to the standard towards Gram-positive bacterial strains. The compounds 5-7, 11-13, and 17-19 displayed two-fold higher activity whereas compound 21 showed four-fold higher antibacterial activity against Staphylococcus aureus MTCC 96 as compared to the standard Neomycin. Some of these compounds exhibited moderate antifungal activity against all the tested fungal strains. Two compounds 16 and 23 showed promising anticancer activity against selected four human cancer cell lines such as A549, DU145, HeLa, and MCF7.
机译:通过利用Baylis-Hillman化学并进一步研究了一系列吡喃衍生物(5-27),并进一步研究了它们的体外抗癌,抗菌和抗真菌活性。 与革兰氏阳性细菌菌株的标准相比,大多数测试化合物表现出有前途的抗菌活性。 与标准新霉素相比,化合物5-7,11-13和17-19显示出较高的活性,而化合物21与金黄色葡萄球菌MTCC 96的抗菌活性较高。 这些化合物中的一些表现出对所有测试的真菌菌株的中等抗真菌活性。 两种化合物16和23显示出对选定的四种人癌细胞系(如A549,DU145,HELA和MCF7)的有前途的抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号